Drugs / Naoxintong Capsule
last change Jun 2025 re-read 3 minutes ago

Naoxintong Capsule

Developed for
atherosclerotic cardiovascular disease
Investigated by
Chinese Academy of Medical Sciences, Fuwai Hospital

Trials 1

2023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT05278182 Dec 2022 → Jun 2025 atherosclerotic cardiovascular disease Chinese Academy of Medical Sciences, Fuwai Hospital Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Naoxintong Capsule ClinicalTrials.gov intervention name — accepted as the source's own label NCT05278182 ↗